STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

“The Adventure Jar,” Showcases a Family Navigating the Challenges of a Cancer Diagnosis and Finding Magic in Time Together

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Gilead Sciences has released a children's book titled 'The Adventure Jar' as part of its ongoing commitment to support families affected by metastatic breast cancer (MBC). The book, created in partnership with the MBC community, illustrates how one family navigates the challenges of a cancer diagnosis while finding joy in their time together. This initiative aims to provide resources and support for people living with MBC, particularly focusing on the impact on children.

Gilead Sciences is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines in areas of unmet medical need. With operations in over 35 countries and headquarters in Foster City, California, Gilead strives to transform and simplify care for people with life-threatening illnesses worldwide.

Loading...
Loading translation...

Positive

  • Demonstrates commitment to supporting families affected by metastatic breast cancer
  • Provides resources for an underserved aspect of cancer care (impact on children)
  • Showcases corporate social responsibility in healthcare

Negative

  • None.

News Market Reaction 1 Alert

+0.05% News Effect

On the day this news was published, GILD gained 0.05%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTHAMPTON, MA / ACCESSWIRE / August 27, 2024 / Gilead Sciences:

Cancer can cause disruption for families and may especially impact children. "The Adventure Jar," created by Gilead in partnership with the metastatic breast cancer community, showcases the perspective of one family navigating the challenges of a diagnosis and finding magic in time together.

This book is part of our ongoing commitment to provide resources and support for people living with MBC.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Download a copy: https://gilead.inc/4e7IWSn

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:

Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View the original press release on accesswire.com

FAQ

What is 'The Adventure Jar' book released by Gilead Sciences (GILD)?

'The Adventure Jar' is a children's book created by Gilead Sciences in partnership with the metastatic breast cancer community. It showcases a family navigating the challenges of a cancer diagnosis while finding magic in their time together.

How does 'The Adventure Jar' support families affected by metastatic breast cancer?

The book provides resources and support for families, particularly children, dealing with the impact of metastatic breast cancer. It helps illustrate how families can find joy and maintain connections despite the challenges of a cancer diagnosis.

Where can I download a copy of 'The Adventure Jar' by Gilead Sciences (GILD)?

You can download a copy of 'The Adventure Jar' from the link provided by Gilead Sciences: https://gilead.inc/4e7IWSn

What is Gilead Sciences' (GILD) focus in the pharmaceutical industry?

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, focusing on life-threatening illnesses worldwide.
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data

152.86B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY